We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Corebridge Financial
CRBG
$14.9B
| $272K | ﹤0.01% |
+13,553
| New | +$286K |
|
1227
AAR Corp
AIR
$5.94B
| $270K | ﹤0.01% |
6,016
-152,440
| -96% | -$6.64M |
|
|
DRD
1228
DRDGold
DRD
$2.1B
| $270K | ﹤0.01% |
+36,458
| New | +$224K |
|
1229
Syndax Pharmaceuticals
SNDX
$1.83B
| $270K | ﹤0.01% |
+10,590
| New | +$247K |
|
1230
Immunocore
IMCR
$1.75B
| $269K | ﹤0.01% |
+4,718
| New | +$266K |
|
1231
Forward Air
FWRD
$636M
| $267K | ﹤0.01% |
2,545
-18,448
| -88% | -$1.94M |
|
1232
Globant
GLOB
$1.63B
| $267K | ﹤0.01% |
+1,590
| New | +$281K |
|
1233
Oneok
OKE
$57.7B
| $265K | ﹤0.01% |
4,029
-1,009,148
| -100% | -$62M |
|
1234
AXIS Capital
AXS
$7.36B
| $262K | ﹤0.01% |
+4,829
| New | +$261K |
|
|
ABCM
1235
DELISTED
Abcam PLC
ABCM
| $260K | ﹤0.01% |
+16,731
| New | +$261K |
|
|
PCTI
1236
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $259K | ﹤0.01% |
60,305
| – | – |
|
1237
Monolithic Power Systems
MPWR
$70.3B
| $257K | ﹤0.01% |
726
-111
| -13% | -$39.9K |
|
|
HPKEW
1238
DELISTED
HighPeak Energy, Inc. Warrant
HPKEW
| $254K | ﹤0.01% |
14,100
| – | – |
|
1239
Howmet Aerospace
HWM
$113B
| $245K | ﹤0.01% |
+6,229
| New | +$227K |
|
1240
Interface
TILE
$2.19B
| $245K | ﹤0.01% |
+24,869
| New | +$261K |
|
1241
Texas Capital Bancshares
TCBI
$4.36B
| $243K | ﹤0.01% |
4,029
-32,443
| -89% | -$1.92M |
|
1242
Titan International
TWI
$450M
| $242K | ﹤0.01% |
+15,821
| New | +$226K |
|
1243
American Outdoor Brands
AOUT
$157M
| $235K | ﹤0.01% |
+23,450
| New | +$218K |
|
1244
Century Casinos
CNTY
$34.3M
| $234K | ﹤0.01% |
33,306
-3,620
| -10% | -$26.5K |
|
|
CVE.WS
1245
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
| $234K | ﹤0.01% |
16,072
| – | – |
|
|
SFIX
1246
Stitch Fix
SFIX
$480M
| $233K | ﹤0.01% |
74,779
+30,410
| +69% | +$114K |
|
1247
Atlantic Union Bankshares
AUB
$6.03B
| $231K | ﹤0.01% |
6,586
-7,917
| -55% | -$271K |
|
|
HTBK
1248
DELISTED
Heritage Commerce
HTBK
| $231K | ﹤0.01% |
+17,792
| New | +$239K |
|
1249
Invesco
IVZ
$13.9B
| $227K | ﹤0.01% |
12,638
-238,526
| -95% | -$4.08M |
|
1250
Northwest Bancshares
NWBI
$2.3B
| $224K | ﹤0.01% |
+15,993
| New | +$231K |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.